Tar Choon Aw | Chemical Pathology | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Tar Choon Aw | Chemical Pathology | Best Researcher Award

Professor (Pathology) at Duke-NUS Graduate Medical School, Singapore

Dr. Tar-Choon Aw is a distinguished academic and clinical expert in laboratory medicine and biochemistry, with a rich career spanning academia, research, and clinical practice. With a strong foundation in both teaching and research, he has made significant contributions to the fields of clinical chemistry, endocrinology, and laboratory management. His extensive experience encompasses working in both university and healthcare settings, where he has led teams and mentored aspiring professionals in the field. Dr. Aw’s research primarily focuses on the accurate measurement and clinical interpretation of biochemical markers, contributing to better patient diagnosis and care. His dedication to the advancement of medical science has been recognized with multiple honors and awards throughout his career.

Professional Profile

Education

Dr. Tar-Choon Aw completed his medical degree (M.B.B.S.) at the University of Singapore, providing him with a solid foundation in medicine and clinical practice. Following his passion for laboratory medicine, he pursued specialization in biochemistry, earning his M.Sc. in Clinical Chemistry from the University of London. To further hone his expertise, he undertook a Ph.D. in Clinical Chemistry from the University of London, where his research emphasized the precision and relevance of biochemical measurements in clinical diagnostics. Dr. Aw has also earned various professional certifications, including the Fellowship of the Royal College of Pathologists (FRCPath), underscoring his commitment to maintaining the highest standards in pathology and laboratory medicine.

Professional Experience

Dr. Tar-Choon Aw has a diverse professional background that bridges academia, research, and clinical practice. He has held key academic positions, including serving as a Professor of Clinical Chemistry, where he has guided research projects and mentored students. In the clinical realm, he has been a leading figure in several hospital laboratories, overseeing quality control and implementing new diagnostic protocols. His role as a consultant in clinical biochemistry has allowed him to collaborate with physicians and healthcare teams to improve patient outcomes through accurate lab testing. Additionally, Dr. Aw has served on numerous editorial boards of scientific journals, contributing to the dissemination of knowledge in clinical chemistry and laboratory medicine.

Research Interests

Dr. Tar-Choon Aw’s research interests are centered around advancing the field of clinical chemistry and laboratory diagnostics. He is particularly focused on the development and validation of novel biomarkers for the early detection and monitoring of diseases, including cardiovascular and metabolic disorders. His work also explores the optimization of laboratory processes to enhance the accuracy and efficiency of biochemical testing, which is critical for timely patient care. Dr. Aw is interested in the clinical applications of endocrinological assays, seeking to better understand the hormonal imbalances in various disease states. His research efforts aim to bridge the gap between laboratory findings and clinical decision-making, ultimately improving patient outcomes.

Research Skills

Dr. Tar-Choon Aw possesses a broad range of research skills that enable him to excel in the field of clinical chemistry and laboratory medicine. He is adept at designing and conducting research studies, with a strong emphasis on the development and evaluation of diagnostic assays. His expertise in statistical analysis allows him to interpret complex data, ensuring that research findings are robust and clinically relevant. Dr. Aw is skilled in using advanced laboratory techniques such as mass spectrometry, immunoassays, and chromatographic methods for the precise measurement of biochemical markers. Additionally, he has significant experience in quality control processes, ensuring the reliability and accuracy of laboratory results, which is critical for both research and clinical settings.

Awards and Honors

Dr. Tar-Choon Aw’s contributions to clinical chemistry and laboratory medicine have earned him numerous awards and honors. He has been recognized for his excellence in teaching and mentoring, receiving accolades from academic institutions for his dedication to nurturing the next generation of medical scientists. His research has been acknowledged by prestigious organizations, including awards for his innovative work in biomarker discovery and laboratory process optimization. Dr. Aw has also received fellowships from esteemed professional bodies, such as the Royal College of Pathologists, which highlights his expertise and standing in the field. These recognitions underscore his commitment to advancing the practice of laboratory medicine and improving patient care through scientific innovation.

Conclusion

Dr. Tar-Choon AW’s extensive expertise, international recognition, and substantial research contributions make him a strong candidate for the Best Researcher Award. His leadership roles, mentorship achievements, and commitment to advancing the field of chemical pathology are commendable. To further strengthen his candidacy, focusing on niche research topics and expanding his global research collaborations could elevate his impact in the field. Overall, Dr. AW’s career accomplishments and dedication to medical science position him as an exemplary researcher deserving of this recognition.

Publications Top Notes

  • Emerging Role of Natriuretic Peptides in Diabetes Care: A Brief Review of Pertinent Recent Literature”
    • Authors: Dipti Tiwari, Tar Choon Aw
    • Year: 2024
    • Journal: Diagnostics
    • DOI: 10.3390/diagnostics14192251
  • “Effects of Oral Nutritional Supplement with β-Hydroxy-β-methylbutyrate (HMB) on Biochemical and Hematological Indices in Community-Dwelling Older Adults at Risk of Malnutrition: Findings from the SHIELD Study”
    • Authors: Siew Ling Tey, Dieu Thi Thu Huynh, Sing Teang Kong, Jeffery Oliver, Geraldine Baggs, Yen Ling Low, Choon How How, Magdalin Cheong, Wai Leng Chow, Ngiap Chuan Tan et al.
    • Year: 2024
    • Journal: Nutrients
    • DOI: 10.3390/nu16152495
  • “The 2024 American Diabetes Association Guidelines on Standards of Medical Care in Diabetes: Key Takeaways for Laboratory”
    • Authors: Dipti Tiwari, Tar Choon Aw
    • Year: 2024
    • Journal: Exploration of Endocrine and Metabolic Diseases
    • DOI: 10.37349/eemd.2024.00013
  • “Anexelekto (AXL) No More: microRNA-155 (miR-155) Controls the ‘Uncontrolled’ in SARS-CoV-2”
    • Authors: K. I. Papadopoulos, A. Papadopoulou, T. C. Aw
    • Year: 2024
    • Journal: Human Cell
    • DOI: 10.1007/s13577-024-01041-6
  • “Optimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review”
    • Authors: Dipti Tiwari, Tar Choon Aw
    • Year: 2023
    • Journal: Diagnostics
    • DOI: 10.3390/diagnostics14010087
  • “Live to Die Another Day: Novel Insights May Explain the Pathophysiology Behind Smoker’s Paradox in SARS-CoV-2 Infection”
    • Authors: K. I. Papadopoulos, A. Papadopoulou, T. C. Aw
    • Year: 2023
    • Journal: Molecular and Cellular Biochemistry
    • DOI: 10.1007/s11010-023-04681-8
  • “Evaluation of the Abbott Alinity i Thyroid-Stimulating Hormone Receptor Antibody (TRAb) Chemiluminescent Microparticle Immunoassay (CMIA)”
    • Authors: Deborah J. W. Lee, Soon Kieng Phua, Yali Liang, Claire Chen, Tar-Choon Aw
    • Year: 2023
    • Journal: Diagnostics
    • DOI: 10.3390/diagnostics13162707
  • “Fluvoxamine Mediates Specific, Early, and Delayed SARS-CoV-2 Protection through Antioxidant and Cytoprotective Pathways via Sigma-1 Receptor Agonism”
    • Authors: Konstantinos Papadopoulos, Alexandra Papadopoulou, Tar Choon Aw
    • Year: 2023
    • Journal: Advanced Pharmaceutical Bulletin
    • DOI: 10.34172/apb.2023.045
  • “Beauty and the Beast: Host microRNA-155 versus SARS-CoV-2”
    • Authors: K. I. Papadopoulos, A. Papadopoulou, T. C. Aw
    • Year: 2023
    • Journal: Human Cell
    • DOI: 10.1007/s13577-023-00867-w
  • “Considerations in Understanding Vaccine Effectiveness”
    • Authors: Chin Shern Lau, Tar Choon Aw
    • Year: 2022
    • Journal: Vaccines
    • DOI: 10.3390/vaccines11010020

 

CANAN AKÜNAL | Clinical Biochemistry | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. CANAN AKÜNAL | Clinical Biochemistry | Best Researcher Award

NEUROLOGY DEPARTMENT LECTURER, ASSOCIATE PROFESSOR at Bolu Abant Izzet Baysal University,Department of Neurology, Faculty of Medicine, Turkey

Dr. Canan Akünal Türel is an Associate Professor in the Department of Neurology at Bolu Abant İzzet Baysal University. She earned her Bachelor’s Degree from Ankara University and completed her specialization at the University of Health Sciences. Her research focuses on neurodegenerative diseases, epilepsy, and the impact of various pharmacological agents on neurological conditions. Dr. Türel has led several national and TÜBİTAK-supported projects investigating the effects of drugs and biomarkers in neurological disorders, including epilepsy and Alzheimer’s disease. She has published extensively in international journals, contributing valuable insights into the electrophysiological and anti-inflammatory effects of different compounds. Her work includes evaluating the role of inflammation and neuroinflammatory biomarkers in various neurological conditions. Additionally, Dr. Türel actively participates in teaching and mentoring students in neurology and related fields. Her dedication to advancing understanding in neurology and her impactful research make her a strong candidate for the Research for Best Researcher Award.

Profile

Education

Dr. Canan Akünal Türel holds an extensive educational background in the field of medicine and neurology. She completed her Bachelor’s Degree at Ankara University, Faculty of Medicine, in June 2005. Following this, she pursued her specialization in Medicine at the University of Health Sciences, Ankara Diskapi Yıldırım Beyazıt Health Research Center, earning her degree on December 28, 2011. Her specialization thesis focused on “Comparing Swallowing Function Disorders in Acute Stroke with Bedside Tests and Electrophysiological Data,” supervised by Bilge Koçer and S. Semih Çomoğlu. Dr. Türel further advanced her expertise through her role as an Associate Professor at Bolu Abant İzzet Baysal University, where she has contributed significantly to the field of neurology. Her academic journey reflects a deep commitment to advancing knowledge in neurology and stroke research.

Professional Experience

Dr. Canan Akünal Türel is an Associate Professor in the Department of Neurology at Bolu Abant İzzet Baysal University, where she has significantly contributed to the field of neurology since August 2018. Her academic journey began with a bachelor’s degree in medicine from Ankara University in 2005, followed by a specialization in medicine at the University of Health Sciences in 2011. She has since supervised numerous theses and engaged in a range of research projects, including studies on epilepsy models and neuroinflammatory biomarkers. Dr. Türel has been involved in national scientific projects and has published extensively in international journals. Her professional roles also include participation in various scientific organizations and teaching courses related to neurological disorders and treatments. Her research interests include epilepsy, neurodegenerative diseases, and the impact of neuroinflammation.

Research Interest

Dr. Canan Akünal Türel is an Associate Professor specializing in neurology with a focus on stroke, epilepsy, and neurodegenerative diseases. Her research explores the electrophysiological and anti-inflammatory effects of various pharmacological agents in experimental models, particularly related to epilepsy and Alzheimer’s disease. Dr. Türel’s work includes investigating the impact of cyclooxygenase inhibition on epileptiform activity, the role of oleanolic acid in seizures, and the effects of novel compounds like esculetin and daidzein on epilepsy. Additionally, her studies delve into the neuroinflammatory biomarkers in acute and chronic neuropathies and the pathophysiological role of infections in neurodegenerative conditions. Dr. Türel also examines the clinical and electrophysiological evaluations in neurological disorders, contributing valuable insights into treatment strategies and disease mechanisms. Her multidisciplinary approach aims to advance the understanding and management of complex neurological conditions through innovative research methodologies.

Research Skills

Dr. Canan Akünal Türel possesses a robust set of research skills underscoring her expertise in neurology and related fields. Her proficiency encompasses both theoretical and practical aspects of medical research. She is adept at conducting complex studies on neurodegenerative diseases, epileptic disorders, and the pharmacological effects of various compounds. Dr. Türel’s research involves advanced techniques such as electrophysiological measurements and inflammatory biomarker analyses. Her work includes supervising doctoral research and managing multiple national and international research projects, reflecting her strong project management and leadership abilities. Dr. Türel has also demonstrated skill in publishing high-impact articles in reputable journals, presenting her findings at scientific conferences, and contributing to academic books. Her comprehensive understanding of neurological diseases and experimental models, combined with her methodological expertise, makes her a significant contributor to her field.

Award and Recognition

Dr. Canan Akünal Türel is an esteemed Associate Professor at Abant İzzet Baysal University, recognized for her significant contributions to neurology and neurophysiology. Her work has been prominently featured in high-impact international journals, including the International Journal of Environmental Health Research and Physiological Reports. Dr. Türel’s research focuses on the electrophysiological and anti-inflammatory effects of various treatments for neurological disorders, such as epilepsy and Alzheimer’s disease. She has received acclaim for her leadership in national scientific projects, notably her roles in investigating the effects of different compounds in experimental epilepsy models and exploring neuroinflammatory biomarkers in neuropathies. Her achievements are further highlighted by her active membership in prestigious scientific organizations and her contributions to national and international conferences. Dr. Türel’s dedication and expertise have established her as a leading figure in her field, making her a deserving candidate for recognition in research excellence.

Conclusion

Dr. Canan Akünal Türel is a strong candidate for the “Best Researcher Award” due to her extensive research experience, significant publication record, and active involvement in academic projects and supervision. Her contributions to neurology, particularly in understanding and treating neurological disorders, are commendable. Addressing areas such as increasing international collaboration and enhancing research visibility could further strengthen her candidacy and impact in the field.

Publications Top Notes

  1. Electrophysiologic and Anti-Inflammatorial Effects of Cyclooxygenase Inhibition in Epileptiform Activity
    • Authors: Akunal Türel, C.; Çelik, H.; Çetinkaya, A.; Türel, İ.
    • Year: 2023
    • Journal: Physiological Reports
    • Volume: 11
    • Issue: 17
    • Article Number: e15800
  2. Oleanolic Acid Suppresses Pentylenetetrazole-Induced Seizure in Vivo
    • Authors: Akünal Türel, C.; Yunusoğlu, O.
    • Year: 2023
    • Journal: International Journal of Environmental Health Research
    • Volume: 33
    • Issue: 5
    • Pages: 529–540
    • Citations: 7
  3. Investigation of the Pharmacological Potential of Myricetin on Alcohol Addiction in Mice
    • Authors: Yunusoğlu, O.; Shahzadi, A.; Akünal Türel, C.; Berköz, M.; Akkan, A.G.
    • Year: 2022
    • Journal: Journal of Research in Pharmacy
    • Volume: 26
    • Issue: 4
    • Pages: 722–733
    • Citations: 3
  4. Evaluation of the Relationship Between Oral Health, Chewing Ability, and Degree of Disease in Alzheimer-Type Dementia Patients
    • Authors: Değirmenci, K.; Akünal Turel, C.
    • Year: 2021
    • Journal: Turk Geriatri Dergisi
    • Volume: 24
    • Issue: 4
    • Pages: 534–545